Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesUltrasoundCEUS impacts 2D shear-wave elastography liver assessmentContrast-enhanced ultrasound (CEUS) performed after 2D elastography could impact liver assessment.AIHow accurate are AI-generated depictions of radiologists?Molecular ImagingExtravasations rare in Lu-177 DOTATATE therapyPractice ManagementNew MR safety codes provide additional reimbursement for radiologistsCTCT, MRI reveal hidden brain changes linked to increased fall risk
